Biologic Utilization Patterns: Data from the International Severe Asthma Registry (ISAR)

Andrew Menzies-Gow; Wang Eileen; Mari-Anne  Rowlands; Marianna Alacqua; Mona Al-Ahmad; Lakmini Bulathsinhala; Victoria Carter; Isha Chaudhry; Borja G. Cosio; Nevaashni Eleangovan; J. Mark FitzGerald; Liam G Heaney; Mark Hew; Naeimeh Hosseini; David Jackson; Maria Kallieri; Désirée Larenas-Linnemann; Stelios Loukides; Njira Lugogo; Ruth B Murray; Andriana I. Papaioannou; Luis Perez de Llano; Celeste Porsbjerg; Linda M. Rasmussen; Johannes Schmid; Trung N Tran; Charlotte Ulrik; John W Upham; David Price

Biologic Utilization Patterns: Data from the International Severe Asthma Registry (ISAR)

Andrew Menzies-Gow
, Wang Eileen
, Mari-Anne Rowlands
, Marianna Alacqua
, Mona Al-Ahmad
, Lakmini Bulathsinhala
, Victoria Carter
, Isha Chaudhry
, Borja G. Cosio
, Nevaashni Eleangovan
, J. Mark FitzGerald
, Liam G Heaney
, Mark Hew
, Naeimeh Hosseini
, David Jackson
, Maria Kallieri
, Désirée Larenas-Linnemann
, Stelios Loukides
, Njira Lugogo
, Ruth B Murray

Andriana I. Papaioannou, Luis Perez de Llano, Celeste Porsbjerg, Linda M. Rasmussen, Johannes Schmid, Trung N Tran, Charlotte Ulrik, John W Upham, David Price

Optimum Patient Care Ltd, Cambridge
Observational and Pragmatic Research Institute Singapore
National Health Service
Son Espases University Hospital-IdISBa-Ciberes
The Institute for Heart Lung Health
Queen's University Belfast
Allergy
National and Kapodistrian University of Athens
Attikon General Hospital
Hospital Universitario Lucus Augusti
University of Copenhagen
AstraZeneca
University of Queensland
Princess Alexandra Hospital Brisbane

Research output: Contribution to conference › Abstract › peer-review

Abstract

Use of biologics in severe asthma has grown dramatically in the last decade. However, little is known about the patterns of biologic use in real-life. Our aim was to describe frequency and patterns of biologic use in an international severe asthma cohort.

Original language	English
Publication status	Published - 20 Mar 2021
Event	6th REG Summit: The Respiratory Effectiveness Group - Virtual Duration: 18 Mar 2021 → 20 Mar 2021 Conference number: 6th https://www.erasmus.gr/microsites/1218

Conference

Conference	6th REG Summit
Period	18/03/21 → 20/03/21
Internet address	https://www.erasmus.gr/microsites/1218

Bibliographical note

Funding: ISAR is conducted by Optimum Patient Care (OPC) Global Limited, and co-funded by OPC Global and AstraZeneca

Cite this

Menzies-Gow, A., Eileen, W., Rowlands, M.-A., Alacqua, M., Al-Ahmad, M., Bulathsinhala, L., Carter, V., Chaudhry, I., Cosio, B. G., Eleangovan, N., FitzGerald, J. M., Heaney, L. G., Hew, M., Hosseini, N., Jackson, D., Kallieri, M., Larenas-Linnemann, D., Loukides, S., Lugogo, N., ... Price, D. (2021). Biologic Utilization Patterns: Data from the International Severe Asthma Registry (ISAR) . Abstract from 6th REG Summit.

Menzies-Gow, A, Eileen, W, Rowlands, M-A, Alacqua, M, Al-Ahmad, M, Bulathsinhala, L, Carter, V, Chaudhry, I, Cosio, BG, Eleangovan, N, FitzGerald, JM, Heaney, LG, Hew, M, Hosseini, N, Jackson, D, Kallieri, M, Larenas-Linnemann, D, Loukides, S, Lugogo, N, Murray, RB, Papaioannou, AI, Perez de Llano, L, Porsbjerg, C, Rasmussen, LM, Schmid, J, Tran, TN, Ulrik, C, Upham, JW & Price, D 2021, 'Biologic Utilization Patterns: Data from the International Severe Asthma Registry (ISAR) ', 6th REG Summit, 18/03/21 - 20/03/21.

@conference{4c2b3c6ed66649dc9d4088a808de794c,

title = "Biologic Utilization Patterns: Data from the International Severe Asthma Registry (ISAR) ",

abstract = "Use of biologics in severe asthma has grown dramatically in the last decade. However, little is known about the patterns of biologic use in real-life. Our aim was to describe frequency and patterns of biologic use in an international severe asthma cohort.",

author = "Andrew Menzies-Gow and Wang Eileen and Mari-Anne Rowlands and Marianna Alacqua and Mona Al-Ahmad and Lakmini Bulathsinhala and Victoria Carter and Isha Chaudhry and Cosio, \{Borja G.\} and Nevaashni Eleangovan and FitzGerald, \{J. Mark\} and Heaney, \{Liam G\} and Mark Hew and Naeimeh Hosseini and David Jackson and Maria Kallieri and D{\'e}sir{\'e}e Larenas-Linnemann and Stelios Loukides and Njira Lugogo and Murray, \{Ruth B\} and Papaioannou, \{Andriana I.\} and \{Perez de Llano\}, Luis and Celeste Porsbjerg and Rasmussen, \{Linda M.\} and Johannes Schmid and Tran, \{Trung N\} and Charlotte Ulrik and Upham, \{John W\} and David Price",

note = "Funding: ISAR is conducted by Optimum Patient Care (OPC) Global Limited, and co-funded by OPC Global and AstraZeneca; 6th REG Summit : The Respiratory Effectiveness Group ; Conference date: 18-03-2021 Through 20-03-2021",

year = "2021",

month = mar,

day = "20",

language = "English",

url = "https://www.erasmus.gr/microsites/1218",

}

TY - CONF

T1 - Biologic Utilization Patterns

T2 - 6th REG Summit

AU - Menzies-Gow, Andrew

AU - Eileen, Wang

AU - Rowlands, Mari-Anne

AU - Alacqua, Marianna

AU - Al-Ahmad, Mona

AU - Bulathsinhala, Lakmini

AU - Carter, Victoria

AU - Chaudhry, Isha

AU - Cosio, Borja G.

AU - Eleangovan, Nevaashni

AU - FitzGerald, J. Mark

AU - Heaney, Liam G

AU - Hew, Mark

AU - Hosseini, Naeimeh

AU - Jackson, David

AU - Kallieri, Maria

AU - Larenas-Linnemann, Désirée

AU - Loukides, Stelios

AU - Lugogo, Njira

AU - Murray, Ruth B

AU - Papaioannou, Andriana I.

AU - Perez de Llano, Luis

AU - Porsbjerg, Celeste

AU - Rasmussen, Linda M.

AU - Schmid, Johannes

AU - Tran, Trung N

AU - Ulrik, Charlotte

AU - Upham, John W

AU - Price, David

N1 - Conference code: 6th

PY - 2021/3/20

Y1 - 2021/3/20

N2 - Use of biologics in severe asthma has grown dramatically in the last decade. However, little is known about the patterns of biologic use in real-life. Our aim was to describe frequency and patterns of biologic use in an international severe asthma cohort.

AB - Use of biologics in severe asthma has grown dramatically in the last decade. However, little is known about the patterns of biologic use in real-life. Our aim was to describe frequency and patterns of biologic use in an international severe asthma cohort.

M3 - Abstract

Y2 - 18 March 2021 through 20 March 2021

ER -

Biologic Utilization Patterns: Data from the International Severe Asthma Registry (ISAR)

Abstract

Conference

Bibliographical note

Fingerprint

Cite this